Safety and effectiveness of transdermal electrical stimulation for non-arteritic anterior ischemic optic neuropathy

Not Applicable

• Conditions: non-arteritic anterior ischemic optic neuropathy

• Registration Number: JPRN-UMIN000036220
• Lead Sponsor: Chiba university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-01
• Study Completion: 2020-06-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with ESR>20 mm/h and CRP>10 mg/L in blood tests. 2. Patients who have been confirmed with nonarteritic ischemic optic neuropathy and who have an eye disease other than ischemic optic neuropathy by contrast-enhanced MRI. 3. Patients who have a history of drug allergy to drugs (mydriatics and anesthetics eye drops) to be used during the trial period. 4. Patients with complications that have a significant affect on visual function. 5. Patients with a history of or complications of malignancy. However, patients who have a history but have not relapsed for more than 5 years can be registered. 6. Patients diagnosed and treated for dementia and mental illness. 7. Patients complicated with poor control diabetes (HbA1c>10.0%). 8. Patients with uncontrollable hypertension systolic>180 mmHg and or diastolic 110 mmHg. 9. Patients with liver / renal dysfunction that falls under any of the following at clinical screening. AST, ALT; more than 3 times the upper limit of facility standard value Serum creatinine; more than 1.5 times the upper limit of institutional standard value 10. Patients taking ethambutol hydrochloride and / or amiodarone hydrochloride. 11. Patients who were pregnant, breastfeeding, may be or planned to be pregnant during the trial period. 12. Patients participating in other clinical trials. 13. Patients under investigational responsibility shared doctors judged inappropriate for participation in this trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
logMAR visual acuity